STOCK TITAN

Pelthos Therapeutics to Present at 38th Annual ROTH Conference

Pelthos Therapeutics (NYSE American: PTHS) announced that CEO Scott Plesha will speak in a fireside chat at the 38th Annual ROTH Conference on March 23, 2026 at 3:00 p.m. PT.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Pelthos Therapeutics (NYSE American: PTHS) announced that CEO Scott Plesha will speak in a fireside chat at the 38th Annual ROTH Conference on March 23, 2026 at 3:00 p.m. PT. A live webcast will be available on the company investor site and replayed for 90 days.

Loading...
Loading translation...

Key Figures

Conference edition: 38th Annual ROTH Conference Event date: March 23, 2026 Presentation time: 3:00 p.m. Pacific Time +1 more
Conference edition
38th Annual ROTH Conference
Event where CEO will speak
Event date
March 23, 2026
Scheduled fireside chat at ROTH
Presentation time
3:00 p.m. Pacific Time
Time of ROTH fireside chat
Webcast replay period
90 days
Replay availability after the event

Historical Context

5 past events · Latest: Mar 09
5 events
  1. Mar 09

    Earnings date announcement

    24h Move
    -0.3%

    Set date and call details for Q4 and full-year 2025 results.

  2. Feb 23

    Conference participation

    24h Move
    +5.0%

    Announced CEO presentation at Oppenheimer healthcare conference with webcast access.

  3. Jan 13

    Debt financing

    24h Move
    -1.3%

    Secured up to $50 million term loan facility to support product launches.

  4. Jan 05

    Product acquisition

    24h Move
    -9.0%

    Acquired FDA-approved Xeglyze lice treatment with no ongoing milestone or royalty payments.

  5. Dec 23

    Board expansion

    24h Move
    -1.8%

    Appointed experienced finance executive Andrew Einhorn to the board and key committees.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

DURHAM, N.C., March 12, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced that CEO Scott Plesha will participate in a fireside chat at the 38th Annual ROTH Conference on March 23, 2026 at 3:00 p.m. Pacific Time.

Investors interested in arranging one-on-one meetings should contact their ROTH representative.

A live webcast of the fireside chat will be available on the News & Events page in the Investors section of the Company’s website at https://pelthos.com. A replay of the webcast will be available for 90 days following the event.

About Pelthos Therapeutics
Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products that address unmet patient needs. ZELSUVMI™ (berdazimer) topical gel, 10.3%, the company’s lead product, is the first and only prescription therapy approved for use at home by patients, parents, and caregivers to treat Molluscum contagiosum. The company’s portfolio of assets also includes Xepi® (ozenoxacin) Cream, 1%, a topical treatment for impetigo, and Xeglyze® (abametapir), a topical treatment for head lice. More information is available at www.pelthos.com. Follow Pelthos on LinkedIn and X.

Contacts
Investors:
LifeSci Advisors, LLC
Mike Moyer, Managing Director
mmoyer@lifesciadvisors.com

Media:
KWM Communications
Kellie Walsh
pelthos@kwmcommunications.com
(914) 315-6072


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Pelthos Therapeutics (PTHS) present at the 38th Annual ROTH Conference?

Pelthos will present on March 23, 2026 at 3:00 p.m. Pacific Time. According to Pelthos, CEO Scott Plesha will participate in a fireside chat, with a live webcast accessible on the company investor website for remote viewers.

How can investors watch the Pelthos (PTHS) fireside chat webcast on March 23, 2026?

Investors can watch the live webcast on the Pelthos investor site. According to Pelthos, the webcast is available via the News & Events page and can be streamed live at the scheduled 3:00 p.m. PT start time.

Will Pelthos (PTHS) provide a replay of the ROTH Conference presentation and for how long?

Yes, a replay will be available for 90 days after the event. According to Pelthos, the recorded fireside chat will remain on the company website for three months following the March 23, 2026 presentation.

Who is the Pelthos (PTHS) executive speaking at the ROTH Conference fireside chat?

CEO Scott Plesha will participate in the fireside chat on March 23, 2026. According to Pelthos, Plesha will represent the company during the 3:00 p.m. PT session to discuss corporate developments and strategy.

How can investors arrange one-on-one meetings with Pelthos (PTHS) at the ROTH Conference?

Investors should contact their ROTH representative to arrange one-on-one meetings. According to Pelthos, meeting scheduling is handled through ROTH, so investors should coordinate directly with their ROTH contact before the March 23, 2026 event.

Keep reading